These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


279 related items for PubMed ID: 15867182

  • 41.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 42. Clinical characteristics and outcomes of hospitalized heart failure patients with systolic dysfunction and chronic obstructive pulmonary disease: findings from OPTIMIZE-HF.
    Mentz RJ, Fiuzat M, Wojdyla DM, Chiswell K, Gheorghiade M, Fonarow GC, O'Connor CM.
    Eur J Heart Fail; 2012 Apr; 14(4):395-403. PubMed ID: 22302663
    [Abstract] [Full Text] [Related]

  • 43.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 44. Day of admission and clinical outcomes for patients hospitalized for heart failure: findings from the Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients With Heart Failure (OPTIMIZE-HF).
    Fonarow GC, Abraham WT, Albert NM, Stough WG, Gheorghiade M, Greenberg BH, O'Connor CM, Nunez E, Yancy CW, Young JB.
    Circ Heart Fail; 2008 May; 1(1):50-7. PubMed ID: 19808270
    [Abstract] [Full Text] [Related]

  • 45.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 46.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 47.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 48.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 49.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 50.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 51. Prognostic significance of serum total cholesterol and triglyceride levels in patients hospitalized for heart failure with reduced ejection fraction (from the EVEREST Trial).
    Greene SJ, Vaduganathan M, Lupi L, Ambrosy AP, Mentz RJ, Konstam MA, Nodari S, Subacius HP, Fonarow GC, Bonow RO, Gheorghiade M, EVEREST Trial Investigators.
    Am J Cardiol; 2013 Feb 15; 111(4):574-81. PubMed ID: 23206923
    [Abstract] [Full Text] [Related]

  • 52.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 53. Rapid Emergency Department Heart Failure Outpatients Trial (REDHOT II): a randomized controlled trial of the effect of serial B-type natriuretic peptide testing on patient management.
    Singer AJ, Birkhahn RH, Guss D, Chandra A, Miller CD, Tiffany B, Levy P, Dunne R, Bastani A, Thode HC, Hollander JE.
    Circ Heart Fail; 2009 Jul 15; 2(4):287-93. PubMed ID: 19808351
    [Abstract] [Full Text] [Related]

  • 54. Worsening renal function in children hospitalized with decompensated heart failure: evidence for a pediatric cardiorenal syndrome?
    Price JF, Mott AR, Dickerson HA, Jefferies JL, Nelson DP, Chang AC, O'Brian Smith E, Towbin JA, Dreyer WJ, Denfield SW, Goldstein SL.
    Pediatr Crit Care Med; 2008 May 15; 9(3):279-84. PubMed ID: 18446113
    [Abstract] [Full Text] [Related]

  • 55. Use of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in patients with congestive heart failure: an observational study of treatment rates and clinical outcome.
    Gotsman I, Rubonivich S, Azaz-Livshits T.
    Isr Med Assoc J; 2008 Mar 15; 10(3):214-8. PubMed ID: 18494235
    [Abstract] [Full Text] [Related]

  • 56. Characteristics of patients hospitalized with acute decompensated heart failure who are referred for hospice care.
    Hauptman PJ, Goodlin SJ, Lopatin M, Costanzo MR, Fonarow GC, Yancy CW.
    Arch Intern Med; 2007 Oct 08; 167(18):1990-7. PubMed ID: 17923600
    [Abstract] [Full Text] [Related]

  • 57.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 58. The prognostic significance of bundle branch block in high-risk chronic stable vascular disease patients: a report from the HOPE trial.
    Sumner G, Salehian O, Yi Q, Healey J, Mathew J, Al-Merri K, Al-Nemer K, Mann JF, Dagenais G, Lonn E, HOPE Investigators.
    J Cardiovasc Electrophysiol; 2009 Jul 08; 20(7):781-7. PubMed ID: 19298567
    [Abstract] [Full Text] [Related]

  • 59. Identifying heart failure patients at high risk for near-term cardiovascular events with serial health status assessments.
    Kosiborod M, Soto GE, Jones PG, Krumholz HM, Weintraub WS, Deedwania P, Spertus JA.
    Circulation; 2007 Apr 17; 115(15):1975-81. PubMed ID: 17420346
    [Abstract] [Full Text] [Related]

  • 60. Rolofylline, an adenosine A1-receptor antagonist, in acute heart failure.
    Massie BM, O'Connor CM, Metra M, Ponikowski P, Teerlink JR, Cotter G, Weatherley BD, Cleland JG, Givertz MM, Voors A, DeLucca P, Mansoor GA, Salerno CM, Bloomfield DM, Dittrich HC, PROTECT Investigators and Committees.
    N Engl J Med; 2010 Oct 07; 363(15):1419-28. PubMed ID: 20925544
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 14.